{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:32:48Z","timestamp":1791196368633,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.schres.2013.11.011","type":"journal-article","created":{"date-parts":[[2013,12,15]],"date-time":"2013-12-15T17:45:25Z","timestamp":1387129525000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia"],"prefix":"10.1016","volume":"152","author":[{"given":"F.M.","family":"Notarangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J.","family":"Horning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.schres.2013.11.011_bb0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02230867","article-title":"Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS","volume":"13","author":"Antinori","year":"1992","journal-title":"Ital. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.schres.2013.11.011_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1432-2277.2004.00031.x","article-title":"Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo","volume":"18","author":"Bauer","year":"2005","journal-title":"Transpl. Int."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"4812","key":"10.1016\/j.schres.2013.11.011_bb0020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bmj.1.4812.702","article-title":"Toxoplasmosis in relation to mental deficiency","volume":"1","author":"Burkinshaw","year":"1953","journal-title":"Br. Med. J."},{"issue":"1\u20132","key":"10.1016\/j.schres.2013.11.011_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(01)00418-0","article-title":"Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages","volume":"120","author":"Chiarugi","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.schres.2013.11.011_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2005-02-0666","article-title":"CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain","volume":"107","author":"Courret","year":"2006","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.schres.2013.11.011_bb0035","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.micinf.2004.07.008","article-title":"Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii","volume":"6","author":"Da Gama","year":"2004","journal-title":"Microbes Infect."},{"issue":"6","key":"10.1016\/j.schres.2013.11.011_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.1994.14.313","article-title":"Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells","volume":"14","author":"Dai","year":"1994","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.schres.2013.11.011_bb0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/978-1-4615-4709-9_64","article-title":"IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism","volume":"467","author":"D\u00e4ubener","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"issue":"20","key":"10.1016\/j.schres.2013.11.011_bb0050","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM197405162902003","article-title":"Congenital toxoplasmosis. A prospective study of 378 pregnancies","volume":"290","author":"Desmonts","year":"1974","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/schbul\/sbm005","article-title":"Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality","volume":"33","author":"Dickerson","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2013.11.011_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.schres.2013.11.011_bb0070","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2307\/3284282","article-title":"Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts","volume":"83","author":"Dubey","year":"1997","journal-title":"J. Parasitol."},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.schres.2013.11.011_bb0075","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00436-012-3015-6","article-title":"Oxidative stress and tryptophan degradation pattern of acute Toxoplasma gondii infection in mice","volume":"111","author":"Engin","year":"2012","journal-title":"Parasitol. Res."},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00023210-200923020-00001","article-title":"Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders","volume":"23","author":"Erhardt","year":"2009","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001756-199701200-00011","article-title":"Activated human microglia produce the excitotoxin quinolinic acid","volume":"8","author":"Espey","year":"1997","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0090","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/schbul\/sbl074","article-title":"Effects of toxoplasma on human behavior","volume":"33","author":"Flegr","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2013.11.011_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/IAI.70.2.779-786.2002","article-title":"L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase","volume":"70","author":"Fujigaki","year":"2002","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.schres.2013.11.011_bb0105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0149-2918(96)80059-2","article-title":"Treatment regimens for patients with toxoplasmic encephalitis","volume":"18","author":"Fung","year":"1996","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.schres.2013.11.011_bb0110","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.schres.2013.11.011_bb0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-5-48","article-title":"Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection","volume":"5","author":"Hermes","year":"2008","journal-title":"J. Neuroinflammation"},{"issue":"Pt 2","key":"10.1016\/j.schres.2013.11.011_bb0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj3200595","article-title":"Human microglia convert l-tryptophan into the neurotoxin quinolinic acid","volume":"320","author":"Heyes","year":"1996","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.schres.2013.11.011_bb0125","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/S0950268810001044","article-title":"Decreased prevalence and age-specific risk factors for Toxoplasma gondii IgG antibodies in The Netherlands between 1995\/1996 and 2006\/2007","volume":"139","author":"Hofhuis","year":"2011","journal-title":"Epidemiol. Infect."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00927816","article-title":"Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis","volume":"70","author":"Johnson","year":"1984","journal-title":"Z. Parasitenkd."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2013.11.011_bb0140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/schbul\/sbs079","article-title":"Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective","volume":"38","author":"Kannan","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2013.11.011_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0002-9343(88)90014-9","article-title":"Treatment of central nervous system toxoplasmosis with pyrimethamine\/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy","volume":"84","author":"Leport","year":"1988","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.schres.2013.11.011_bb0150","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1128\/IAI.73.8.5160-5165.2005","article-title":"Experimental ocular toxoplasmosis in genetically susceptible and resistant mice","volume":"73","author":"Lu","year":"2005","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/138920007780362518","article-title":"Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines","volume":"8","author":"MacKenzie","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"10.1016\/j.schres.2013.11.011_bb0160","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"issue":"9425","key":"10.1016\/j.schres.2013.11.011_bb0165","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00702-011-0763-x","article-title":"Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery","volume":"119","author":"Moroni","year":"2012","journal-title":"J. Neural Transm."},{"issue":"1\u20133","key":"10.1016\/j.schres.2013.11.011_bb0175","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.schres.2012.08.036","article-title":"Prevalence of antibodies to Toxoplasma gondii in patients with schizophrenia and mood disorders","volume":"142","author":"Nascimento","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.11.011_bb9000","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ab.2011.12.032","article-title":"Gas chromatography\/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain","volume":"421","author":"Notarangelo","year":"2012","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.schres.2013.11.011_bb0180","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1460-9568.2012.08064.x","article-title":"Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood","volume":"35","author":"Pocivavsek","year":"2012","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.schres.2013.11.011_bb0185","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2013.11.011_bb0190","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/eji.200939535","article-title":"Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase","volume":"39","author":"Schmidt","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0195","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/schbul\/sbm030","article-title":"Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?","volume":"33","author":"Schwarcz","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2013.11.011_bb0200","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2013.11.011_bb0205","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0210","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/IAI.70.2.859-868.2002","article-title":"Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1","volume":"70","author":"Silva","year":"2002","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.schres.2013.11.011_bb0220","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","article-title":"Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism","volume":"5","author":"Taylor","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.schres.2013.11.011_bb0225","first-page":"663.29","article-title":"Behavioral abnormalities in mice deficient in kynurenine 3-monooxygenase: Relevance to schizophrenia","volume":"27","author":"Thomas","year":"2012","journal-title":"Soc. Neurosci. Abstr."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0230","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2013.11.011_bb0235","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"15","key":"10.1016\/j.schres.2013.11.011_bb0240","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1073\/pnas.0608310104","article-title":"Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors","volume":"104","author":"Vyas","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.schres.2013.11.011_bb0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0447.2006.00780.x","article-title":"Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia","volume":"114","author":"Wang","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"issue":"1589","key":"10.1016\/j.schres.2013.11.011_bb0250","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1098\/rspb.2005.3413","article-title":"Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour","volume":"273","author":"Webster","year":"2006","journal-title":"Proc. Biol. Sci."},{"issue":"5","key":"10.1016\/j.schres.2013.11.011_bb0255","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijpara.2003.12.010","article-title":"The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis","volume":"34","author":"Wilson","year":"2004","journal-title":"Int. J. Parasitol."},{"issue":"5","key":"10.1016\/j.schres.2013.11.011_bb0260","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","article-title":"Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection","volume":"66","author":"Wilson","year":"1980","journal-title":"Pediatrics"},{"issue":"1\u20132","key":"10.1016\/j.schres.2013.11.011_bb0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2005.04.018","article-title":"A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis","volume":"165","author":"Wilson","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.schres.2013.11.011_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413006075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413006075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T20:06:23Z","timestamp":1647720383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996413006075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0920996413006075"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2013.11.011","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: Implications for schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2013.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}